Skip to main content

Advertisement

SpringerLink
Log in

Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance

  • Regular Paper
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

Abstract

Angiogenesis, which plays a key role in the development of astrocytic gliomas, depends on the local balance between various molecules that induce and inhibit neovascularization. Whereas recent experimental studies have indicated that cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) regulate angiogenesis by modulating vascular endothelial growth factor (VEGF) production, little is known about the relationships among expression of these markers, angiogenesis, and clinical outcome in astrocytic glioma cases. We therefore examined immunohistochemical expression of COX-2, iNOS, and VEGF in 51 high-grade astrocytomas including 31 glioblastomas (grade IV) and 20 anaplastic astrocytomas (grade III), 49 low-grade astrocytomas (grade II), and 43 reactive astrogliosis specimens, and determined the relationship with microvessel density (MVD) and prognostic significance. Stepwise increase of immunoreactive scores for COX-2, iNOS, and VEGF was found from astrogliosis, through low-grade to high-grade astrocytoma. The COX-2 expression strongly correlated with iNOS, VEGF, and high MVD, both overall and in all tumors, whereas iNOS expression was weakly associated with VEGF and high MVD. Univariate analysis revealed a significant association between COX-2 overexpression and a poor outcome. The findings for COX-2 and VEGF-related angiogenesis raise the possibility that the COX-2 pathway may contribute to astrocytic tumorigenesis by promoting new vessel formation with prognostic implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A–I
Fig. 2A–D
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Achiwa H, Yatabe Y, Hida T, Kuroishi T, Kozaki K, Nakamura S, Ogawa M, Sugiura T, Mitsudomi T, Takahashi T (1999) Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res 5:1001–1005

    CAS  PubMed  Google Scholar 

  2. Bredt DS, Synder SH (1992) Nitric oxide, a novel neuronal messenger. Neuron 8:3–11

    CAS  PubMed  Google Scholar 

  3. Castelli MG, Chiabrando C, Fanelli R, Martelli L, Butti G, Gaetani P, Paoletti P (1989) Prostaglandin and thromboxane synthesis by human intracranial tumors. Cancer Res 49:1505–1508

    CAS  PubMed  Google Scholar 

  4. Cianchi F, Cortesini C, Fantappie O, Messerini L, Schiavon N, Vannacci A, Nistri S, Sardi I, Baroni G, Marzocca C, Perna F, Mazzanti R, Bechi P, Masini E (2003) Inducible nitric oxide synthase expression in human colorectal cancer. Am J Pathol 162:793–801

    CAS  PubMed  Google Scholar 

  5. Dubois RN, Abraham SB, Crofford L, Gupta R, Simon L, Van De Pantle L, Lipsky P (1998) Cyclooxygenase in biology and disease. FASEB J 12:1063–1073

    CAS  PubMed  Google Scholar 

  6. Eberhart CE, Coffey RJ, Radhika A, Giardiells F, Ferrenbach S, DuBois R (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188

    CAS  PubMed  Google Scholar 

  7. Fujiwaki R, Iida K, Kawasaki H, Ozaki T, Hata K, Miyazaki K (2002) Cyclooxygenase-2 expression in endometrial cancer: correlation with microvessel count and expression of vascular endothelial growth factor and thymidine phosphorylase. Human Pathol 33:213–219

    Article  CAS  Google Scholar 

  8. Gallo O, Masini E, Bianchi B, Brushini L, Paglerani M, Franchi A (2002) Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Human Pathol 33:708–714

    Article  CAS  Google Scholar 

  9. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–356

    PubMed  Google Scholar 

  10. Hida T, Yatabe Y, Achiwa H, Muramatsu H, Kozaki K, Nakamura S, Ogawa M, Mitsudomi T, Sugiura T, Takahashi T (1998) Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res 58:3761–3764

    CAS  PubMed  Google Scholar 

  11. Joki T, Hesse O, Nikas DC, Bello L, Zhang J, Kraeft S, Seyfried N, Abe N, Chen L, Carroll R, Black P (2000) Expression of cyclooxygenase-2 in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60:4926–4931

    CAS  PubMed  Google Scholar 

  12. Kieser A, Weich H, Brandner G (1994) Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9:963–969

    CAS  PubMed  Google Scholar 

  13. Kim YM, deVera ME, Watkins SC, Billiar T (1997) Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272:1402–1411

    CAS  PubMed  Google Scholar 

  14. Kim YM, Talanian RV, Billiar TR (1997) Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 272:31138–31148

    Article  CAS  PubMed  Google Scholar 

  15. Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, Kuroe I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishii H (1998) Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxinitrite in colonic mucosa of patients with active ulcerative colitis. Gut 42:180–187

    CAS  PubMed  Google Scholar 

  16. Landino LM, Crews BC, Timmons MD, Morrow JD, Marnett LJ (1996) Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci USA 93:15069–15074

    Article  CAS  PubMed  Google Scholar 

  17. Majima M, Amano H, Hayashi I (2001) Angiogenic and prostaglandin. Folia Pharmacol Jpn 117:283–292

    CAS  Google Scholar 

  18. Mannick JB, Miao XO, Stamler JS (1997) Nitric oxide inhibits Fas-induced apoptosis. J Biol Chem 272:24125–24128

    Article  CAS  PubMed  Google Scholar 

  19. Marrogi AJ, Travis WD, Welsh JA, Khan MA, Rahim H, Tazelaar H, Pairolero P, Trastek V, Jett J, Caporasone, Liotta LA, Harris CC (2000) Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin Cancer Res 6:4739–4744

    CAS  PubMed  Google Scholar 

  20. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012

    CAS  PubMed  Google Scholar 

  21. Nose F, Ichikawa T, Fujiwara M, Okayasu I (2002) Up-regulation of cyclooxygenase-2 expression in lymphotic thyroiditis and thyroid tumors. Anat Pathol 117:546–551

    CAS  Google Scholar 

  22. Rao CV, Indranie C, Simi B, Manning PT, Connor JR, Readdy BS (2002) Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 62:165–170

    CAS  PubMed  Google Scholar 

  23. Sawada T (1999) Angiogenic factor of brain tumor. No-Shinkei 51:404–410

    Google Scholar 

  24. Sawaoka H, Tsuji S, Tsuji M, Edhi S, Sasaki Y, Kawano S, Hori M (1999) Cyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo. Lab Invest 79:1469–1478

    CAS  PubMed  Google Scholar 

  25. Shirvani VN, Ouatu-Lascar R, Kaur BS, Omary MB, Triadafilopoulos G (2000) Cyxlooxygenase-2 expression in Barrett’s esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 118:487–496

    CAS  PubMed  Google Scholar 

  26. Shono T, Philip J, Janet MB, Olubunmi O, Frederick F (2001) Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61:4375–4381

    CAS  PubMed  Google Scholar 

  27. Sinicrope F, Ruan S, Cleary K, Stephens L, Lee J, Levin B (1995) bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res 55:237–241

    CAS  PubMed  Google Scholar 

  28. Sung JJ, Leung WK, Go MY, To KF, Cheng AS, Ng EK, Chan FK (2000) Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions. Am J Pathol 157:729–735

    CAS  PubMed  Google Scholar 

  29. Takekawa Y, Sawada T, Sakurai I (1997) Neovascular basement membrane and its significance in the biological behavior of astrocytic tumors. Neuropathology 17:196–200

    Google Scholar 

  30. Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 90:1529–1536

    Article  CAS  PubMed  Google Scholar 

  31. Thomsen LL, Scott JMJ, Topley P, Knowles RG, Keerie AJ, Frend AJ (1997) Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo. Studies with 1400 W, a novel inhibitor. Cancer Res 57:3300–3304

    CAS  PubMed  Google Scholar 

  32. Tomozawa S, Tsuno N.H, Sunami E, Hatano K, Kitayama J, Osada T, Saito S, Tsuruo T, Shibata Y, Nagawa H (2000) Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially hematogenous metastasis, of colorectal cancer. Br J Cancer 83:324–328

    Google Scholar 

  33. Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois R (1998) Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705–716

    CAS  PubMed  Google Scholar 

  34. Uefuji K, Ichikura T, Mochizuki H (2000) Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer. Clin Cancer Res 5:135–138

    Google Scholar 

  35. Weidner N, Semple JP, William R (1991) Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 324:1–8

    CAS  PubMed  Google Scholar 

  36. Zimmermann K, Sarbia M, Weber AA (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59:198–204

    CAS  PubMed  Google Scholar 

Download references

Acknowledgement

The authors are grateful to H. Oka, Department of Neurosurgery, Kitasato University of School of Medicine, for providing fresh tissue samples.

Author information

Authors and Affiliations

  1. Department of Pathology, Kitasato University School of Medicine, 1-15-1 Kitasato, 228-8555, Sagamihara, Kanagawa, Japan

    Atsuko Hara & Isao Okayasu

Authors
  1. Atsuko Hara
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Isao Okayasu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Atsuko Hara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hara, A., Okayasu, I. Cyclooxygenase-2 and inducible nitric oxide synthase expression in human astrocytic gliomas: correlation with angiogenesis and prognostic significance. Acta Neuropathol 108, 43–48 (2004). https://doi.org/10.1007/s00401-004-0860-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-004-0860-0

Keywords

Search

Navigation